Home › Business & Finance › Olympus Shares Plunge After FDA Warning Letter on Six Facilities
Business & Finance

Olympus Shares Plunge After FDA Warning Letter on Six Facilities

Key Points

Health Olympus Shares Plunge After FDA Warning Letter on Six Facilities Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities. The company’s stock slumped as much as 17% in Tokyo. The letter relates to quality management system and process observations made after inspections conducted in late 2025, Olympus said in a...

Health Olympus Shares Plunge After FDA Warning Letter on Six Facilities Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities. The company’s stock slumped as much as 17% in Tokyo. The letter relates to quality management system and process observations made after inspections conducted in late 2025, Olympus said in a filing Tuesday. The warning will not disrupt production and its not expected to impact financial results, it said.
Olympus Shares Plunge (ORG) FDA (ORG) Six Facilities Health Olympus (ORG) Six Facilities Olympus Corp. (ORG) the US Food and Drug Administration (ORG) Japanese (ORG) Tokyo (LOCATION) Olympus (ORG)
Originally published by Bloomberg Markets Read original →